Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin

Prevalence of diabetes mellitus is inc6reasing, with a burden of 382 million patients worldwide at present (more than the entire US population). The International Diabetes Federation anticipates an increase up to 592 million patients by 2035. Another major problem arises from the fact that just 50%...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nutr Diabetes
Main Authors: Haas, B, Eckstein, N, Pfeifer, V, Mayer, P, Hass, M D S
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2014
Assuntos:
Mini Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259905/
https://ncbi.nlm.nih.gov/pubmed/25365416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nutd.2014.40
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares